semaglutide and claritin A new American study explored how GLP‑1 medications (like or tirzepatide) might affect MCAS symptoms. Researchers didn't set out to study MCAS: they simply noticed that some patients who were prescribed NW Integrative Medicine: Semaglutide Treatment

Benefits Naturally increases testosterone Supports fertility Restores hormonal balance after disruption Dose: 200300 mcg daily, subcutaneous

Although lupus patients were not part of the original clinical trials for GLP-1 RAs, this new data indicates that the drugs could significantly improve outcomes for those battling lupus-related complications

Long-term considerations Maintenance dosing After reaching goal weight: Some continue at therapeutic dose indefinitely Others may reduce to lower maintenance dose (4-8 mg) Weight regain is common if medication is stopped Long-term studies are ongoing Duration of treatment Based on clinical trial data: Weight loss continues for at least 48-68 weeks Plateau may not occur even at 48 weeks Long-term (multi-year) data not yet available Treatment may be indefinite for weight maintenance Monitoring recommendations Regular check-ins should include: Weight and body composition Blood pressure and heart rate Blood glucose and HbA1c Lipid panel Liver and kidney function Review of symptoms and side effects Frequently asked questions What is the starting dose for retatrutide

Ejaz P, Bhojani K, Joshi VR (2004) NSAIDs and kidney

Gonadotropin releasing hormone release from the rat hypothalamus: dependence on membrane depolarization and calcium influx